期刊文献+

抗AGR2单克隆抗体的制备、鉴定及初步应用 被引量:4

Preparation,characterization and potential application of monoclonal antibody 18A4 against AGR2
下载PDF
导出
摘要 目的:制备鼠抗AGR2单克隆抗体(mAb)并对其特性进行鉴定及其初步应用研究。方法:以AGR2-MBP融合蛋白免疫BALB/c小鼠,采用杂交瘤技术制备鼠抗AGR2的mAb,并用Protein-G亲和层析法纯化mAb。用间接ELISA法测定mAb的效价,以Western blot鉴定mAb的特异性。用免疫荧光、免疫沉淀和MTT法对mAb进行初步应用研究。结果:获得1株可持续、稳定分泌抗AGR2的mAb的杂交瘤细胞。杂交瘤细胞分泌的mAb的Ig亚类(型)为IgG1(κ),腹水mAb的效价达1×10-6。Western blot检测显示,在Mr为20000处有1条清晰的带。免疫荧光显示,该mAb可与乳腺癌细胞中的AGR2蛋白结合。免疫沉淀证实该mAb可与天然状态的AGR2有效结合。MTT实验显示该mAb对乳腺癌细胞MCF7的生长有抑制作用。结论:制备出的鼠抗AGR2的mAb效价高、特异性良好,可抑制细胞的生长,有一定的应用价值,为进一步研究AGR2的功能及其在乳腺癌、前列腺癌等癌症的诊断和治疗中的作用提供了工具。 AIM:To prepare mouse monoclonal antibodies(mAb)against AGR2(human homolog of xenopus anterior gradient 2),to characterize these antibodies' properties,and to develop potential applications.METHODS:BALB/c mice were immunized with AGR2-MBP(maltose binding protein)fusion protein.The mAb was prepared by hybridoma technique and purified by protein G affinity chromatography.The titer and specificity of the mAb was determined by ELISA and Western blot respectively.The mAb was then further characterized by immunoprecipitation,immunofluorescent staining and tumor cell inhibition assay.RESULTS:One clone of hybridoma,18A4,secreting specific mAb against AGR2,was obtained.The Ig subclass of the mAb was IgG1(κ).The titer of the mAb was 1×10^-6.Western blot analysis showed specific binding of 18A4 with both recombinant and native AGR2 in cell extract.Immunofluorescent staining using 18A4 mAb demonstrated specific staining of AGR2 in the cytoplasma of Breast cancer cell line MCF7.Immunoprecipitation as say confirmed that this mAb could specifically bind and effectively precipitate the native AGR2.mAb 18A4 could also inhibit the growth of breast cancer cell MCF7.CONCLUSION:The mAb anti-AGR2 with high titer and specificity has been obtained.This mAb,18A4,can be used in most molecular biology studies including Western blot,immunostaining,immunoprecipitation.It also inhibited the growth of cancer cells and therefore is a potential therapeutic starting point.It is a useful tool for the functional study of AGR2 and for the diagnosis and potential treatment of certain cancers.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第1期49-51,55,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30771211)
关键词 AGR2 单克隆抗体 肿瘤诊断 治疗性抗体 AGR2 mAb cancer diagnosis therapeutic antibody
  • 相关文献

参考文献8

  • 1Petek E, Windpassinger C, Egger H, et al. Localizationl of the human anterior gradient-2 gene ( AGR2 ) to chromosome band 7p21.3 by radiation hybrid mapping and fluorescencein situ hybridization [J]. Cytogenet Cell Genet, 2000, 89(3 -4) : 141 -142.
  • 2Florian RF, Edgar D, Stefan P, et al. Prognostic relevance of AGR2 expression in breast cancer [ J ]. Clin Cancer Res, 2006, 12 (6) : 1728 - 1734.
  • 3Fletcher GC, Patel S, Tyson K, et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene CA. 4a and dystroglycan[J]. Br J Cancer, 2003, 88(4) : 579 -585.
  • 4Zhang JS, Gong A, Cheville JC, et al. AGR2, an androgen-inducible secretory protein overexpresscd in prostate cancer [ J]. Gen Chromo Canc, 2005, 43 (3) : 249 - 259.
  • 5Zhang Y, Forootan SS, Liu D, et al. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients[ J ]. PCPD, 2007, 10 (3) : 293 - 300.
  • 6Fritzsche FR, Dahl E, Dankof A, et al. Expression of AGR2 in non small cell lung cancer[ J ]. Histol Histopathol, 2007, 22 (7) : 703 - 708.
  • 7石晓娟,毛伟平,张双全,姜平,赵洁明.B淋巴细胞刺激物单克隆抗体的制备与特性鉴定[J].细胞与分子免疫学杂志,2005,21(3):328-329. 被引量:5
  • 8孙中文,陶然,陆艳红,石云杰,於葛华,邱玉华,张学光.5株鼠抗人CD28单克隆抗体的研制及生物学特性的研究[J].中国免疫学杂志,2005,21(6):406-410. 被引量:11

二级参考文献11

  • 1邱玉华,张学光,谢炜,朱学东.一种显著提高小鼠生产单抗腹水产量的新方法[J].中国免疫学杂志,1995,11(6):366-367. 被引量:27
  • 2Sanjay DK, Ildiko S, Xia XZ, et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice[J]. Proc Natl Acad Sci,2000, 97(7): 3370-3375.
  • 3Schneider P, MacKay F, Steiner V, et al. BAFF, a nevol ligand of the tumor necrosis factor family, stimulates B cell growth [J]. Exp Med, 1999, 189(11): 1747- 1752.
  • 4Martster SA, Yan M, Pitti RM, et al. Iteraction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI[J]. Curr Biol, 2000, 404(6781): 785 -788.
  • 5Huard B, Schneider P, Mauri D, et al. T cell costimulation by the TNF ligand BAFF[J]. Immunology, 2001, 167(11):6225 -6231.
  • 6Zhang J, Roschke V, Baker KP, et al. A role for B lymphocyte stimulator in systemic lupus erythematosus [J]. Immunology, 2001, 166(1): 6-10.
  • 7Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases[J]. Arthritis Rheum, 2001,44(6): 1313 -1319.
  • 8Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren' s syndrome[J]. Clin Iuvest, 2002, 109(1): 59-68.
  • 9Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J]. J Exp Med, 1999, 190(11): 1697- 1710.
  • 10孙中文,张学光,邱玉华.免疫突触与协同刺激分子[J].上海免疫学杂志,2003,23(3):214-216. 被引量:6

共引文献13

同被引文献49

  • 1张倩,杨振,张艳贞,王爱丽,安学丽,晏月明.蛋白质糖基化修饰的研究方法及其应用[J].生物技术通报,2006,22(1):46-49. 被引量:6
  • 2Logsdon CD, Ramachandran V, Arumugam T, et al. Anterior gradi- ent 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival [J]. Cancer Research, 2008, 68(19): 7811-7818.
  • 3Fritzsche FR, Dahl E, Dankof A, et al. Expression of AGR2 in non smaU cell lung cancer[J]. Histol I-Iistopathol, 2007, 22(7): 703-708.
  • 4Innes HE, Liu D, Barraclougla R, et al. Significance of the metasta- sis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients[J]. Br J Cancer, 2006, 94(7): 1057-1065.
  • 5Fritzschc FR, Dahl E, Pahl S, et al. Prognostic relevance of AGR2 ex- pression in breast cancer[J]. Clin Cancer Rcs, 2006, 12(6): 1728-1734.
  • 6Liu D, Rudland PS, Sibson DR, et al. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carci- nomas[J]. Cancer Res, 2005, 65(9): 3796-3805.
  • 7Ramachandran V, Arumugam T, Wang H, et al. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival [J]. Cancer Res, 2008, 68 (19): 7811-7818.
  • 8Zhang Y, Ali TZ, Zlaou H, et al. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate ean- cer[J]. Cancer Res, 2010,70( 1): 240-248.
  • 9Vanderlaag KE, Hudak S, Bald L, et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin[J]. Breast Cancer Res, 2010, 12(3): R32.
  • 10Berk BC, Fujiwara K, and Lehoux S. ECM remodeling in hyperten- sive heart disease[J]. J Clin Invest, 2007, 117(3): 568-575.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部